Mama Natura® News

Mothers like Insectolin - an recommend it!

Karlsruhe, August 2016

Mothers like Insectolin - an recommend it!

Product convinces with pleasant properties and immediate effect

A product test with 200 mothers and their children brought again overwhelmingly positive feedback for mama natura by DHU: 91 % of mothers like the new Insectolin Gel and 89 % would recommend it to friends and family members.

NetMoms like Insectolin

Insectolin convinced the netmoms.de community with its cooling effect which soothes irritated and reddened skin immediately. Mothers also like it because it is suitable even for babies and little children, helps reduce inflammation of insect bites, has a very pleasant smell, does not burn and shows a high tolerability altogether. The NetMoms website for Insectolin gives an overview of mothers' feedback and the key product benefits.

Dentokind®: recommended by 91 % of mothers

Karlsruhe, May 2016

Dentokind®: recommended by 91 % of mothers

Dentokind® (Dentilin® in Germany) received excellent feedback from end-consumers from the very beginning. It helps children with teething problems, is well tolerated even by babies and easy to administer.

This positive feedback has now been confirmed in a project in Germany: 679 mothers and their babies participated in a sampling project and tested during three weeks the teething gel with organic mallow extract and Panthenol.

They shared their experiences with their friends and families and gave conclusive and overwhelmingly positive feedback: 91 % of them would recommend Dentokind® to treat teething problems in babies and children!

 

Insectolin®: takes the sting out of it …

Karlsruhe, April 2016

Insectolin®: takes the sting out of it …

… this is what users say about Insectolin gel. It alleviates the itching and swelling of insect bites, cools the bitten area, has a very pleasant smell and is suitable for everyone. Including babies of 0 years of age and pregnant or breastfeeding women.

Insectolin was brought to the German market in April 2016 – just right for the season! It convinces with its fresh and pleasant smell and an immediately cooling effect.

Insectolin, a mama natura® product, can be used by the entire young family. It contains caring Jojoba oil and the natural ingredients Echinacea, Hamamelis virginiana, Urtica urens and Ledum palustre.

 

 

 

Travelin® – keeps you going

Karlsruhe, April 2016

Travelin® – keeps you going

… and makes your travel sickness stays at home.

Travelin is a homeopathic medicine to alleviate typical symptoms of travel sickness in a gentle way: nausea and vomiting, vertigo, headache. It has just been launched in Germany and is available in pharmacies.

With this form of application, Travelin is particularly recommendable for children up to 12 years of age, the age group most frequently affected by travel sickness.

Cocculus, the main ingredient of Travelin, is both effective and tolerable. Travelin does not impair concentration or reactivity and does not cause drowsiness.

Travelin is suitable for the entire family, including children as of one year of age, school children and adults.

Dentokind® Teething Gel is toothfriendly!

Karlsruhe, Januar 2016

Dentokind® Teething Gel is toothfriendly!

Dentokind®, the mama natura teething gel, has been tested positive by independent dentists as being "safe for teeth" and is allowed to display the "Toothfriendly" logo.

Dentokind® was featured in the January Newsletter of the "Toothfriendly International" Association where an article on "Sugar-free OTC medicine" underlined the trend in OTC medicine towards sugar-free varieties as consumers become more and more health-conscious.

The certificate is not only proof of Dentokind® meeting parents' demand for sugar-free medicines, but it is also a strong endorsement for a product that helps babies with their first teeth.

DHU is now also a partner of “Toothfriendly International”

mama natura® once more on the winners podium

Karlsruhe, 30 November 2015

mama natura® once more on the winners podium

The global brand concept of mama natura® was awarded the second prize of the GLOBAL2015 award offered by the Chamber of Industry and Commerce in DHU’s German home town, Karlsruhe, and the Karlsruhe TechnologyRegion, a local association promoting business and research.

A global brand, but not a “one-size-fits-all”

mama natura® is a product line of naturally effective treatments especially developed for babies and children. With its name and logo, mama natura speaks the language of mothers worldwide and conveys a sense of naturalness and trust in the gentle authority of mothers, who are still today – across all cultures – responsible for the health of their families. Yet, taking local cultural environments into consideration, mama natura® chooses different ways to get in touch and communicate with mothers, e.g. in the Netherlands, Italy, Germany, Bulgaria and Spain.

mama natura® comes to Germany!

Karlsruhe, 1 October 2015

mama natura® comes to Germany!

Since 1st October, the international brand has been available in German pharmacies – very much to the delight and relief of parents in Germany who look for natural solutions for everyday ailments in babies and children.

The German product line encompasses four products, covering the most frequent ailments in babies and children, like teething problems (Dentilin®), flatulence and meteorism (Bellilin®), respiratory tract infections (Bronchilin®) as well as nervous disorders and restlessness (Zappelin®). All products are available in pharmacies.

Keep in touch with us on facebook. Become a fan yourself and join the quickly growing and very lively community of mama natura®!

Plus, our German mama natura website offers comprehensive information on the products and the underlying causes of your baby’s or child’s ailments, gives useful tips and answers frequent question.

VIVA MAMA NATURA IN ITALIA!

Bolzano, 15 January 2015

VIVA MAMA NATURA IN ITALIA!

Loacker Remedia brings mama natura® to Italy – and offers parents and children naturally effective treatment options for frequent ailments in babies and children.

The four new products cover relevant indications in babies and children and provide quick relief:
Colikind® drops alleviate baby colics.
Dentokind® baby gel helps babies handle teething problems.
Dermakind® soothes diaper rash and skin reddening.
Sebokind® helps babies get rid of cradle cap.

Ask your paediatrician or pharmacist for advice! You will also find comprehensive information on our Italian mama natura website.

Mama Natura® wins the silver!

Karlsruhe, 24 February 2014

In 2011, DHU created an umbrella brand for global roll-out, developed specifically for children, under the name ‘mama natura®’. The portfolio comprises homeopathic combination products that are indicated for common mild ailments and problems that children are exposed to, at different phases of their life, from 0-6 years.

The market launch of the brand was initiated and executed by DHU Iberica, Spain in the same year.

In July 2013, the DHU International division, with their branding agency Dew Gibbons & Partners, submitted the ‘mama natura®’ brand to the DBA Design Effectiveness Awards 2014.

The DBA Design Effectiveness Awards are run annually, and are the UK's most vocal champion of the role of effective design in the creation of business growth. It is the only award scheme that uses commercial data as key judging criteria. They demonstrate the importance of integration of the design brief with business aims and objectives, and the submitted case studies also serve to demonstrate the return on investment that a coherent, well-thought-out and professionally executed design strategy can achieve. http://www.effectivedesign.org.uk/

There were 19 categories that a brand could enter into and ‘mama natura®’ was submitted into the ‘Brand Identity’. Hundreds of entries were submitted, and at the end of 2013, 69 brands were notified that they would receive Gold, Silver or Bronze at the official awards, and ‘mama natura®’ was announced as one of the 69 winners!

On 13th February 2014, two directors of DHU Germany and Iberica attended the prestigious DBA Design Effectiveness Awards gala evening, as guests of the branding agency, Dew Gibbons & Partners, and it was announced that ‘mama natura®’ had received the Silver award!

 

Deutsche Homöopathie-Union celebrates 50th company anniversary

Karlsruhe, 09 July 2011

“In the midst of medicine” was the motto, under which Deutsche Homöopathie-Union (DHU) celebrated its 50-year existence in Karlsruhe on 09 July. Founded in 1961, today the business has 500 employees and is the market-leading manufacturer of homeopathic preparations and Schüssler salts in Germany. DHU’s experience in manufacturing and marketing homeopathic medications already dates back to the year 1866, when Dr. Carl Emil Willmar Schwabe founded the “Central Homeopathic Dispensary - Dr. Willmar Schwabe” in Leipzig. DHU originated from the Schwabe company and is now a sister company within the Schwabe group.

In his official speech, the President of the Lower Saxony Academy of Homeopathy and Naturopathy, Professor Volker Fintelmann, emphasised that an important characteristic of homeopathic medicines is their good tolerability. The secret lies in the fact that their effectiveness is exclusively mediated via stimulation of the body’s own self-healing powers.

In his words of welcome, the Lord Mayor of Karlsruhe, Heinz Fenrich expressed his joy at having DHU, as such a successful company, present in the city. He commended the noticeable interaction of tradition and modern techniques, seen, for example, in continuing traditional succussion by hand amid state-of-the-art technical equipment.

The Managing Director of DHU, Patrick Krauth, emphasised the point that the motto “In the midst of medicine” has long been a reality for homeopathy. In Germany, Europe and most parts of the world, it constitutes part of the “normal” therapy option. Also, from a medico-scientific aspect, homeopathy has long since been present within the midst of medicine. DHU Managing Director Franz Stempfle invited the anniversary celebration guests to the planting of a sequoia tree. This tree embodies many characteristics of the company such as size, stability and endurance and is – like DHU – something special. According to Stempfle, the tree, which grows to become many hundreds of years old, shall at the same time also act as a symbol for constant growth.

A sequoia tree is planted in the grounds of DHU in celebration of the 50th company anniversary: (from left:) District president of the administrative district of Karlsruhe Dr. Rudolf Kühner, Schwabe Group consultant Dr. Klaus-Peter Schwabe, DHU Managing Director Franz Stempfle, DHU Managing Director Patrick Krauth, Schwabe Group consultant Dr. Wolf-Dietrich Schwabe, Lord Mayor of the city of Karlsruhe Heinz Fenrich.

 

In the midst of medicine: 50 years DHU

Karlsruhe, 15 June 2011

Law of similars and potentisation is the hallmark of an ingenious therapeutic method created by Samuel Hahnemann over 200 years ago: homeopathy. The distinguishing feature of the method, to be able to effectively, gently and inexpensively treat diseases through activation of self-healing powers, is more topical today than ever.

According to a representative study of the Forsa Institute dating from 2010, in Germany, half of those questioned have already used homeopathy. A survey from “BKK Health” (Betriebskrankenkasse: Company Health Insurance Funds) revealed that over 80 percent believe in the effective power of homeopathic substances. The users applying them very frequently are almost all satisfied with effectiveness and tolerability of the medications (Forsa).

For Deutsche Homöopathie-Union (DHU), “In the midst of medicine” is thus the logical motto of their 50th company anniversary. The Karlsruhe firm is a market-leading manufacturer of homeopathic medicines in Germany. The expertise in this sector already extends back 145 years and began in 1866 in the newly founded company of Dr. Willmar Schwabe in Leipzig.

50 years ago at Schwabe, homeopathy was separated from the herbal preparations sector. Manufacture and marketing of homeopathic medicines, including the Schüssler salts, were transferred to the DHU. It was founded in 1961 and, since 1969, has been run as an independent company within the Schwabe Group.

Today, Deutsche Homöopathie-Union ranks among the three worldwide greats in the field of homeopathy. Through ten interacting companies and many international partners, DHU preparations are present in over 40 countries of the world. The spectrum comprises single remedies, Dr. Schüssler salts, Specialities, Pentarkane® (complex substance) and veterinary medicines in many different dosage forms. Among these, the globules are the most frequently used form of medication. DHU produces twelve-and-a-half billion a year of these. With barely 500 employees, the company offers 420,000 different products, 14,000 of which are held in stock. DHU produces 73,000 individual items a year.

It is estimated that half a billion people in the world use homeopathic medications. There exists a global trend towards medications from the natural sector. DHU not only meets the demand for them, but also offers a diversity of information and events. DHU is ready to help and provide answers wherever expertise and know-how are required in the field of homeopathy.

 

DHU receives award as ECOfit company

Karlsruhe, 18 October 2010

On 18 October 2010, Deutsche Homöopathie-Union received the award of an ECOfit company. ECOfit is an environmental advice programme of the state of Baden-Württemberg for medium-sized companies. Since 2005, ECOfit has been implemented in over 15 rural districts and towns in cooperation with the company Arqum (consulting firm for health and safety at work, quality control and environmental management). The aim of the programme is to improve environmental and climate protection and simultaneously save resources and costs. Deutsche Homöopathie-Union set itself this challenge last year, in order to also be exemplary in the environmental and climate sector. In the ECOfit programme, analyses of the actual situation are carried out with the participating companies and, together, measures are developed to improve the status quo in the field of environmental and climate protection.

In eight workshops, DHU participants, together with external advisors, worked over the most important environmental protection issues. The workshops were supplemented with four individual consultation sessions led by Arqum. The fact that 52 guidelines and laws alone, of relevance to DHU, in the fields of environment and occupational safety, were identified and re-examined, demonstrates the high significance of the project.

DHU environmental team: Dr. Erwin Pfleging (Dr. Willmar Schwabe), Reino Löffler, Dr. Harald Orth and Jörg Schneider (from left) with the ECOfit certificate.

As a result of the ECOfit project, a higher recycling quota could be attained, e.g. in the field of waste management, through the introduction of the systematic separation of paper and residual waste in the offices. Following analyses for more efficient energy utilisation, further optimisation possibilities arose. Their implementation is currently being prepared by DHU environmental team members, Reino Löffler, Dr. Erwin Pfleging and Jörg Schneider. A comprehensive environmental guideline was compiled for DHU based on the results of the collaboration.

DHU successfully passed the final committee inspection and thus belongs to the first six distinguished companies from the urban district of Karlsruhe. On 18 October, DHU environmental team accepted the award in the town hall of Karlsruhe. Based on this project, DHU will be more active in future in taking on issues relevant to the protection of the environment and climate.

 

Allensbach study provides evidence: The population trusts homeopathy

Karlsruhe, 19 August 2009

Homeopathic medications are a concept known to almost all Germans. They are used and appreciated by more than half of German citizens. That is the result of a representative population survey by the Institute for Opinion Polls in Allensbach. The Federal Association of Pharmaceutical Manufacturers, reg. soc. (Bundesverband der Arzneimittel-Hersteller e. V., B.A.H.), to which Deutsche Homöopathie-Union is also affiliated, had commissioned the study. Nowadays, almost the entire population in Germany is familiar with the term “homeopathic medication” (92 percent). Around 35 years ago, in 1975, only 76 percent of the West German population had heard of homeopathic remedies. Knowledge of the specifics of homeopathic preparations has also increased in Germany on a long-term basis. Today, approximately every sixth citizen spontaneously characterises homeopathic medications, without being given any specifications, about the principle of dilution or law of similars.

The circle of users has grown even more intensely than awareness in the last 40 years. While, in 1970, only virtually every fourth citizen of West Germany had ever taken homeopathic substances, today, at 57 percent, this figure has clearly more than doubled. Also, throughout the whole of Germany, the majority of the population (53 percent) is now using homeopathic medications, the greater proportion being women (64 percent). In total, one quarter of the population are dedicated users of homeopathic medications, i.e. they use homeopathic preparations and are convinced of their efficacy with no reservations (25 percent). A further 26 percent use these medications, but refrain, however, from passing clear judgement on their efficacy. By contrast, only 2 percent of the population consider homeopathic substances to be ineffective despite their own experiences.

The vast majority of non-users to date can imagine taking homeopathic substances in the future or at least does not rule out the possibility of doing so. Among these potential users, in total one third of the population (33 percent), there is an outstandingly abundant representation of young men, people from low principal-income households as well as those on statutory health insurance. Only 14 percent of the population reject the use of homeopathic medications, without having any experience of their own.

The pathway to homeopathic medication is predominantly via personal recommendations by close acquaintances (54 percent) or a physician or pharmacist (37 percent and 31 percent). In addition, explicit prescription from a physician (22 percent), but also medical reporting in newspapers, magazines, radio and television (21 percent) plays a role – however, rarely information from the internet (4 percent).

Users of homeopathic substances report on their successful application especially for colds and flu-like infections (60 percent). In addition, homeopathic remedies are also successfully used by many against a broad spectrum of different disease manifestations: from gastric and intestinal ailments, headache and insomnia to nervousness, skin diseases and circulation disorders to bronchitis, support in convalescence from diseases and the treatment of sports injuries. Two thirds of the population acknowledge homeopathic medications as having virtually no side effects (65 percent), a good half emphatically considers them to be well tolerated (52 percent). There is hardly any fear of adverse combined effects upon consumption together with other medications (10 percent) and only a minority considers a prescription from the physician or natural health professional necessary (26 percent).

Doors open for homeopathy in the EU

Karlsruhe, 08 April 2009

European Member of Parliament Daniel Caspary supports dialogue between manufacturers of homeopathic medications and the EU. Daniel Caspary, member of the European Parliament and representative of the administrative district of Karlsruhe, visited the German Homeopathy Union in Karlsruhe on Monday, 06 April 2009. The EU Member of Parliament obtained an overview of the challenges, which manufacturers of homeopathic and anthroposophical medications are faced with through EU legislation, and offered his support in the dialogue between the company and the responsible EU committees. Daniel Caspary was accompanied by Sven Maier, member of the local council of the city of Karlsruhe (CDU).

The visiting politicians were informed by representatives of the German Homeopathy Union and their colleagues from the companies Organic Remedies Heel (Baden-Baden), WALA Remedies (Bad Boll) and Weleda (Göppingen), of their concerns. The companies collaborate closely to campaign throughout Germany and Europe for better general conditions for their medications. Serving as platforms for these efforts are the Homeopathy and Anthroposophy Competence Forum, an initiative of the BPI State Association of Baden-Württemberg and its member companies, and - at European level - the European Coalition on Homeopathic and Anthroposophic Medicinal Products E.E.I.G. (ECHAMP).

From left: Wolf-Ingo Gobin (WALA Remedies), Barbara Sterner (Weleda), Max Daege (Organic Remedies Heel, ECHAMP President), Dr. Gesine Klein (Head of the Science Group, DHU), Carola Maute-Stephan (BPI Managing Director, State Association of Baden-Württemberg), Daniel Caspary (Member of the European Parliament and representative of the administrative district of Karlsruhe), Sven Maier (Member of the local council of the city of Karlsruhe), Franz Stempfle (DHU Managing Director), Dr. Harald Orth (Head of Pharmacy/Manufacturing, DHU)

The DHU, Germany’s market leader in the manufacturing of homeopathic medications, processes around 1,400 source materials in various potencies (dilutions), dosage forms and pack sizes. This yields a supply spectrum constituting over 400,000 preparations. This large assortment of medications involves particular organisational and technical effort with high costs on the part of the manufacturer, typical for all manufacturers of homeopathic and anthroposophic medications. Daniel Caspary became convinced of this during a tour through the modern production rooms. So far, medications of so-called special therapy orientations are incompletely regulated in the EU. Therefore, laws and regulations for conventional medications are often also applied to them, with no consideration for their particularities. This can lead to considerable problems for their manufacturers, as, for example, made clear by the discussion on legible formats on labels and package inserts.

More and more people in Germany and Europe are familiar with and use homeopathic medications. To be able to continue to offer these inexpensively and in a wide range, more appropriate regulations are necessary on the part of the EU, DHU Managing Director Franz Stempfle pointed out.

Daniel Caspary pledged his support, “to create awareness for homeopathy and the associated specific requirements at EU level.” The doors of the EU Commission are open for all issues, however “many Commission officials are lacking insight into the individual companies.” The information deficits resulting from this lead to a European policy, which inhibits growth and development of homeopathic medications and prevents European harmonisation and free trading of goods.

The European Member of Parliament welcomed the national and European initiatives of the companies of the special therapy orientations to accompany the decision processes in Europe early on with their expert and practical knowledge and to express their needs.

Press release contact & further information

Further information:
Deutsche Homöopathie-Union (DHU)
Ottostrasse 24
76227 Karlsruhe
Phone +49 721-4093-429
Fax +49 721-4093-8429

Sitemap

Legal Disclaimer

The website mama-natura.com has been designed to give users first and general information about the DHU's drugs like e.g. Colikind® and the indication for which it is intended. The products are available in many countries worldwide. However, they are subject to authorizations and regulations which differ from country to country. Therefore, in any case, before starting to use any DHU products always consult your doctor, your pharmacy or the package insert in YOUR home country in order to obtain complete and - up-to-date information which is valid for your country. This website is designated only for the use by persons not domiciled in the Federal Republic of Germany or in Switzerland. The website is explicitly not addressed to persons living in Germany or Switzerland, in which the publication of information as described herein may be restricted. Persons, who are subject to any such restriction as to their residence, nationality or other reasons, are not allowed to use this website.